m+Medelevator.RU
← Поиск публикаций
Leukemia research reports · 2026

Machine learning models in predictive factors for megaloblastic character of macrocytic anemia.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kechida Melek, Kenani Mohamed, Slama Nader, Mili Manel, Salem Aminetou, Krit Wassim, Khochtali Ines, Boukhris Sarra, Abdallah Asma Ben, Bedoui Mohamed Hedi

Аннотация

BACKGROUND: Differentiating megaloblastic from non-megaloblastic macrocytic anemia usually relies on vitamin B12 and/or B9 assessment and bone marrow examination. In resource-limited regions, these diagnostic tools are not readily available. This study aims to develop a machine learning model to distinguish between these two forms of macrocytic anemia using commonly accessible clinical and laboratory parameters.

METHODS: A logistic regression model was developed using a dataset containing clinical features and routine laboratory data. Key predictive variables were identified through the SequentialFeatureSelector. The model was optimized using GridSearchCV and validated through stratified 5-fold cross-validation to ensure robust performance.

RESULTS: ESR, glossitis, and MCHC were the most influential variables in predicting non-megaloblastic anemia, with respective importance percentages of 23.11 %, 22.07 %, and 13.87 %. Other variables such as LDH (13.77 %), aregenerative status (13.42 %), and limb paresthesia (11.78 %) also contributed significantly to the model, while MCV had a comparatively lower importance (1.98 %). The model demonstrated a high discriminatory ability, with an area under the ROC curve (AUC) of 0.92 and an overall accuracy of 94 %. Learning curve analysis confirmed its stability and consistent performance across varying data sizes.

CONCLUSIONS: By reducing dependence on specialized diagnostic tests and invasive procedures, this approach is particularly suited for resource-constrained healthcare settings.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты